Addiction Medicine Made Easy | Fighting back against addiction

Addiction doesn’t just hijack one person, it reorganises the whole family around fear, guilt, and constant crisis. We sit down with interventionist Mike Loverde, founder of Family First Intervention, to talk about what actually happens inside families when substance use disorder takes over and why “waiting until they want help” can quietly become the plan that keeps everyone stuck.

We dig into family systems theory in plain language and name the roles that show up again and again: the enabler who cannot hold the line, the hero who tries to be perfect and can sabotage the process, the martyr who fears being left behind if recovery happens, plus the scapegoat and the lost child. Mike explains how these roles aren’t character flaws, they’re coping strategies that become barriers to treatment, and why changing the family environment is a major predictor of outcomes in addiction recovery.

We also walk through what a professional, structured intervention can look like when it’s done with compassion: tight decision-making, clear boundaries, letters that avoid attacks, and practical planning that pre-handles every “what about…” excuse (work, pets, travel, money). Then we talk aftercare, fact-checking manipulation, preventing AMA discharges, and the difference between enabling and helping, all with real examples families will recognise.

If you found this useful, subscribe, share it with someone supporting a loved one, and leave a rating or review so more families can find the help they need.

To learn more about Mike's work: https://family-intervention.com/

To buy Mike's book: https://a.co/d/0aXdYP7N

To contact Dr. Grover: ammadeeasy@fastmail.com

Cravings, relapse, and “bad choices” make a lot more sense when you view addiction as a brain network problem. We sit down with Dr Philip Yam, a psychiatrist at Serenity Mental Health Centers and former active duty Navy psychiatrist, to get a practical, plain-English look at two treatments that keep coming up in mental health and addiction care: transcranial magnetic stimulation (TMS) and ketamine therapy.

We start with TMS: what it is, how it uses electromagnetic pulses to stimulate specific brain regions, and why targeting the prefrontal cortex can improve regulation over limbic “fight or flight” circuits tied to depression, PTSD, anxiety, ADHD, and substance use disorder. Then we zoom in on addiction-focused protocols that target the insula, a key hub for cravings and decision making, and talk about what a real TMS course looks like, including standard multi-week schedules and accelerated options.

Next we pivot to ketamine infusion for treatment-resistant depression and suicidality, including the glutamate and neuroplasticity story, why low-dose ketamine is not the same as anesthetic dosing, and how dosing is individualized. We also tackle the hard part: ketamine is a drug of abuse. We talk ketamine bladder, why clinics keep it controlled, and how we think about risk when someone has a polysubstance history. We close with how and when combining ketamine with TMS can help, and a decision framework for choosing what to try first.

If this conversation helps you think differently about recovery and brain-based treatment, subscribe, share it with a colleague or friend, and leave a review so more people can find the show.

To contact Dr. Grover: ammadeeasy@fastmail.com

Create Harmony

This is a podcast about setting an intentional rhythm, savoring life’s blessings and...

Listen on: Apple Podcasts Spotify

Vaping looks sleek, smells sweet, and gets marketed like a harmless upgrade from cigarettes, but the science and the bedside reality are messier than most people realize. We walk through why e-cigarettes became popular in the first place, starting with a blunt truth: combustible tobacco is one of the most toxic things humans routinely use, and nicotine dependence is powerful. That “need for a safer cigarette” helped launch a global industry that now delivers nicotine in faster, stronger, more appealing ways than early e-cigarettes ever could.

From there, we get practical and specific about what a vape is and what it does. We break down the basic hardware (battery, heating coil, liquid tank) and how the market evolved from cigarette lookalikes to pens, mods, pods, and today’s disposable devices built around flavors and convenience. Then we dig into the e-liquid itself: nicotine plus solvents like propylene glycol and vegetable glycerin, along with flavoring agents. When those liquids are heated into an aerosol, chemical reactions create new byproducts, and users may also inhale metals shed from the coil. If you’ve ever wondered what you’re actually pulling into your lungs with each puff, this section will sharpen your questions fast.

The core medical focus is EVALI, or e-cigarette and vaping acute lung injury. We explain the symptoms (cough, shortness of breath, low oxygen, fluid in the lungs), why it can be mistaken for asthma, pneumonia, bronchitis, or even COVID, and why clinicians often diagnose it by ruling out other causes. We also cover why THC cartridges and refillable products raised risk in the 2019 outbreak, including what researchers learned about vitamin E acetate and toxic exposure when it’s heated. We close with what prognosis can look like, from improvement after stopping to permanent lung damage.

If this helped you think more clearly about vaping risks, share it with someone who vapes, then subscribe and leave a rating or review so more people can find the show.

To contact Dr. Grover: ammadeeasy@fastmail.com

Create Harmony

This is a podcast about setting an intentional rhythm, savoring life’s blessings and...

Listen on: Apple Podcasts Spotify

“Lived experience” is one of the most powerful tools in addiction medicine, and one of the easiest ways to accidentally get it wrong. When we tell a patient “I’ve been there,” we can create instant trust and reduce shame. We can also, without meaning to, steer care toward our own story, our own recovery path, or our own triggers.

I sit down with Randall Law, a psychiatry physician assistant in Idaho who works in residential and outpatient addiction treatment with a heavy focus on dual diagnosis. Randall shares his own mental health journey, including an episode of manic psychosis that spiraled into a life-threatening crisis in Hawaii during COVID, and how he rebuilt his life and returned to clinical practice. We talk openly about anxiety, stability, and the daily work of staying well while caring for patients in some of their hardest moments.

From there we get practical: when should a clinician share personal history, and when should we keep it private? Randall lays out simple decision rules for self-disclosure, and I share ways I flag the difference between anecdote and evidence so patients know what they are hearing. We also discuss validating psychosis without reinforcing delusions, why motivational interviewing and bedside manner are not “extras” in psychiatry, and how lived experience can support both patient recovery and provider resilience.

If this conversation helps you think differently about boundaries, bias, peer support, or compassionate communication, please subscribe, share the episode with a colleague, and leave a review so more people can find the show.

To contact Dr. Grover: ammadeeasy@fastmail.com

Create Harmony

This is a podcast about setting an intentional rhythm, savoring life’s blessings and...

Listen on: Apple Podcasts Spotify

Most CBD products leave clinicians and patients guessing: unclear labels, inconsistent dosing, and the lingering worry of THC exposure. I’m Dr. Casey Grover, and as an addiction medicine physician I came into this conversation skeptical because I treat cannabis use disorder and I’ve seen how “cannabis-adjacent” products can go sideways in real life. Then I sat down with Pulak Sharma, founder and CEO of Kazmira Therapeutics, and Dr. Marwaha, an internal medicine physician, to dig into what changes when CBD is treated like a true medical therapy rather than a supplement.

We talk about what “prescription-grade” CBD actually means, including 503A compounding standards, a vertically integrated process, and why THC-free purity matters for prescribing, drug testing concerns, and patient safety. Dr. Marwaha shares how he’s using high-dose pure cannabidiol as an adjunct for generalized anxiety and chronic pain, especially in older adults who can’t tolerate NSAIDs or who become confused or sedated on typical options like gabapentin or muscle relaxers. We also get practical about what to monitor: medication interactions, liver function tests, and the real-world side effects he sees most often, like drowsiness and nausea.

We don’t dodge the evidence gaps. Instead, we discuss how structured outcomes tracking (think GAD-7 and PHQ-9) could build credible data around reduced reliance on benzodiazepines, opioids, and other higher-risk meds, and how telemedicine may expand access while keeping protocols consistent. We even explore what’s next, from nanoemulsion tech for faster onset to endometriosis pain and veterinary use where THC can be toxic to pets.

Subscribe, share this with a skeptical friend, and leave a review so more people can find the show.

To contact Dr. Grover: ammadeeasy@fastmail.com

To learn more about Kazmira's work: https://www.kazmiratx.com/

Create Harmony

This is a podcast about setting an intentional rhythm, savoring life’s blessings and...

Listen on: Apple Podcasts Spotify

One-med-at-a-time sounds tidy on paper, but alcohol use disorder rarely behaves like a tidy problem. Dr. Reb Close and I sat down to discuss treating alcohol use disorder, and we’ve learned that many patients do better when we treat AUD the way we treat other chronic conditions: with a multimodal plan that targets more than one pathway and stays anchored to the person’s real reason for drinking.

We walk through how we think about combination medication strategies for alcohol cravings, including naltrexone, acamprosate, gabapentin, baclofen, and topiramate. You’ll hear the practical “why” behind pairing meds, how we set expectations for naltrexone response, and how targeted dosing can give patients more control during high-risk moments. We also talk about monthly extended-release naltrexone (Vivitrol) and how we approach add-on oral dosing without overdoing it.

Just as important, we keep coming back to the central clinical question: what does alcohol do for you? If drinking is driven by anxiety, insomnia, or trauma, the best AUD treatment may start with sleep, PTSD symptoms, nightmares, or triggers rather than another anti-craving pill. We close by zooming out to what best practice really looks like: therapy or groups, good sleep, nutrition, exercise, treatment of co-occurring mental health conditions, and more than one medication when it fits.

Subscribe for more practical addiction medicine, share this with a clinician or friend who cares about recovery, and please leave a review so more people can find the show.

To contact Dr. Grover: ammadeeasy@fastmailcom

Burnout doesn’t always announce itself with a crash. Sometimes it creeps in while you’re still achieving, still leading, still doing “all the right things” until you notice you’re dreading shifts, snapping at people you love, or feeling numb with patients. That’s where our conversation goes, with James Maskalyk, an emergency physician in downtown Toronto, the first wellness director in his division, and someone who has helped bring emergency medicine training and wellness thinking to Ethiopia.

We get honest about what high-stress healthcare work does to the body and mind: shift work, chronic cortisol, trauma exposure, PTSD, and the subtle slide into depersonalisation. We also talk about the system problem, not just the individual problem, when pay and performance are tied to throughput instead of the quality of care and the humanity of the clinician. Along the way, we share the moments that changed how we see “wellness,” including the realization that medicine is an act of empathy and you can’t pour from an empty cup.

Then we move into practical, real-world tools: taking meaningful time away (including month-long sabbaticals), creating space inside the ER for small moments of connection, building peer support, and doing debriefs that help teams process what they just lived through. We also discuss journaling, creative work, and therapy as ways to build vocabulary for what you’re carrying so you can make changes earlier, not years later. If this resonates, subscribe, share it with a colleague, and leave a review so more healthcare workers can find it.

To contact Dr. Grover: ammadeeasy@fastmail.com

Dr. Maskalyk's substack: https://jamesmaskalyk.substack.com/

Create Harmony

This is a podcast about setting an intentional rhythm, savoring life’s blessings and...

Listen on: Apple Podcasts Spotify

The idea sounds caring and practical: if my teen is going to drink anyway, I’d rather it happen at home where I can supervise it. I’m Dr. Casey Grover, and after years in emergency medicine and now addiction medicine, I keep hearing this “safe at home” approach framed as a way to teach responsible drinking and prevent future addiction. The problem is that good intentions are not the same as good outcomes, and the research on parental permission is far less comforting than most families expect.

We walk through six studies that directly test whether allowing underage alcohol use (and the same logic often applied to cannabis) provides a protective effect. Across surveys and longitudinal data, the pattern points in one direction: permissive attitudes and permission to drink at home are associated with more frequent use, higher quantities, and more alcohol-related harms later on. We dig into findings on teens drinking without parental knowledge, the risk of alcohol being taken from the home, and how early “sips” or “tastes” can predict heavier drinking in late adolescence even after controlling for other factors.

We also get practical about what helps. The evidence supports clear boundaries, consistent discipline around drinking, and direct communication about risks. One of the most sobering insights is how often parents underestimate how much teens drink, especially when parents believe that controlled access at meals is protective. If you’re a parent, caregiver, clinician, or student, you’ll leave with concrete takeaways you can use in real conversations at home and in the clinic.

If this was useful, subscribe, share it with someone raising a teen, and please leave a review so more people can find Addiction Medicine Made Easy. Huge thanks to Central Coast Overdose Prevention for supporting the show, and remember: treating addiction saves lives.

To contact Dr. Grover: ammadeeasy@fastmail.com

Getting someone from fentanyl to buprenorphine can be one of the hardest transitions in addiction medicine, and not because people “don’t want it.” The pharmacology is unforgiving: start too soon and precipitated withdrawal can hit fast, loud, and memorable enough that patients never want to try bupe again. We sit down with Dr. Reb Close to talk through a newer approach that’s gaining traction, Direct To Inject (DTI), and what it looks like when you actually do it in the real world.

We explain why fentanyl’s long tail changes everything, then map the options we offer patients: macrodosing, microdosing with a cross taper, microdosing without a cross taper, and DTI. You’ll hear how DTI uses a weekly long-acting injectable buprenorphine dose that comes on over about 24 hours, effectively creating a built-in “microdose ramp” while the patient navigates that first day. We also get specific about comfort meds, safety counselling, and how we handle the common moment where someone feels terrible but hasn’t taken any of the meds meant to help.

From street-based care to clinic workflows, we share what withdrawal severity looks like across patients, when DTI is not a good option, how we think about methadone switches, and why we often push toward high-dose monthly injectable buprenorphine for a longer protective tail. If you care about practical fentanyl-era buprenorphine induction, retention, and overdose prevention, this one is for you. Subscribe, share with a colleague, and leave a review so more people can find the show.

To contact Dr. Grover: ammadeeasy@fastmail.com

Create Harmony

This is a podcast about setting an intentional rhythm, savoring life’s blessings and...

Listen on: Apple Podcasts Spotify

Walking out of treatment can feel like being dropped right back into the fire: the bills are higher, relationships are still strained, triggers are everywhere, and the old “solution” of numbing out is suddenly right there again. We wanted a clearer answer to a common question from patients, families, and clinicians: what is sober living, and how does it actually help?

I sit down with Gerald Lott, host of the Seeds of Recovery podcast, author, and executive director of Sauk Valley Voices of Recovery in Illinois. Gerald breaks down sober living as real-life practice with guardrails: peer-led structure, house rules, curfews, chores, and meeting requirements that taper over time. We also talk about the differences between a recovery home (treatment without walls), sober living, Oxford House style models, and why it’s essential to vet programmes carefully because predatory sober homes do exist.

A huge thread running through our conversation is connection. Gerald explains why recovery built only on shared trauma can fade as you stabilise, and how “tribe” and affinity groups like sports, music, fishing, running, art, and service can keep connection growing in long-term recovery. We get practical about life skills too: budgeting, work routines, repairing relationships, and how recovery coaching turns big goals into weekly steps.

If you care about addiction recovery, relapse prevention, sober living programmes, or how peer recovery specialists support lasting change, this one is for you. Subscribe, share with someone who needs a next step after treatment, and leave a review so more people can find the show.

* Note * - there is some adult language in this episode

To contact Dr. Grover: ammadeeasy@fastmail.com

Create Harmony

This is a podcast about setting an intentional rhythm, savoring life’s blessings and...

Listen on: Apple Podcasts Spotify

GLP-1 medications are everywhere right now, and not just because people are losing weight. We’re starting to see something far more interesting for addiction medicine: semaglutide may reduce alcohol cravings and heavy drinking, and early data hints it could influence other compulsive behaviors too. I recorded this talk after giving it as a lecture to my colleagues, and it’s one I’ve wanted to share for a long time because the science is moving fast and the clinical questions are piling up.

We walk through what GLP-1 drugs actually are, how gut hormones like GLP-1 and GIP shape appetite, digestion, and glycaemic control, and why side effects like nausea and bloating are so common. I also clear up the most confusing practical point patients run into: Ozempic versus Wegovy and Mounjaro versus Zepbound are often the same molecules labelled for different indications, and insurance coverage usually follows those rules.

Then we get into the addiction evidence. I review three recent randomized controlled trials from 2025 to 2026 studying semaglutide for alcohol use disorder, including injectable and oral versions. The results aren’t magic, but they’re meaningful: fewer drinks on drinking days, fewer heavy drinking days, and lower craving scores compared with placebo, plus secondary findings that raise new research questions about nicotine and cannabis. Finally, I share two de-identified patient cases that show why GLP-1s can be a game-changer for some people and only a small nudge for others, especially when depression, grief, anxiety, or PTSD is the true engine behind drinking.

If this helped you think differently about recovery tools, subscribe, share the show with a colleague or friend, and leave a review so more people can find it.

To contact Dr. Grover: ammadeeasy@fastmail.com

Create Harmony

This is a podcast about setting an intentional rhythm, savoring life’s blessings and...

Listen on: Apple Podcasts Spotify

In this episode, Dr. Grover sits down with his daughter to discuss some of the more subtle aspects of quitting smoking. If you're wondering why it was his daughter, well - she was home when the recording was happening and it just felt right.

Smoking isn’t just nicotine, it’s a whole stress ritual hiding in plain sight. We’ve both seen it: someone can do the brutal work of getting sober from alcohol or stopping opioids, yet cigarettes or vaping stay glued to their day. So we slow down and ask a more honest question: if nicotine gum, lozenges, and patches can cover withdrawal, why does quitting smoking still take so many serious attempts?

We break nicotine dependence down in plain language, including why nicotine can feel like both an upper and a downer, what nicotine withdrawal looks like, and how nicotine replacement therapy fits into a real smoking cessation plan. Then we get into the part people rarely name: the behavioral addiction. The hand-to-mouth routine becomes automatic, and the body starts craving the motion and timing just as much as the chemical.

From there we lay out three hidden reinforcers that make smoking and vaping feel calming: paced breathing that works like an anxiety exercise, the built-in permission of a smoke break, and the walk away from people that restrictions and stigma often force. We also connect this to early recovery and post-acute withdrawal syndrome (PAWS), when the brain is already dysregulated and anxiety can run high at work. If quitting removes your breathing, breaks, and escape all at once, of course cravings surge.

Listen for practical ways to replace the ritual without keeping the smoke: schedule breaks on purpose, keep the walk, practice box breathing, and use evidence-based supports when needed. If this helps you or someone you love, subscribe, share the episode, and leave a review so more people can find it.

To contact Dr. Grover: ammadeeasy@fastmail.com

Polysubstance use is where addiction medicine stops being a single-problem visit and becomes real clinical triage. When someone is using alcohol, fentanyl, methamphetamine, benzodiazepines, cannabis, nicotine, and whatever else is in the supply, the hardest part is not naming the diagnosis, it’s deciding what to treat first and how to do it safely. We brought back a remastered conversation with Monterey addiction physician Dr Lee Goldman to walk through the thinking that keeps patients alive and keeps clinicians from getting lost in overlapping symptoms.

We talk through how we build the “priority list” using the patient’s own reason for coming in, the dysfunction the substance is causing, and objective tools like urine toxicology while remembering that some sedatives may not show up. Dr Goldman explains why alcohol withdrawal risk often rises to the top, how fentanyl changes buprenorphine inductions through precipitated withdrawal, and why unknown medications like Soma or unmentioned methadone can derail an otherwise solid plan. You’ll hear why many clinicians stabilise one withdrawal syndrome at a time, and what harm reduction looks like when “stop everything today” is not realistic.

We also get honest about the messy questions: what does sobriety mean when someone says they’re “sober” but still using cannabis, benzodiazepines, or kratom? How do residential, partial hospital, IOP, and outpatient settings change what we can require and what we can monitor? Why is nicotine so normalised in recovery spaces, and when is the right time to address it? Dr Goldman makes a strong case that benzodiazepines may be the toughest substance to treat, especially with anxiety and PTSD in the background, and we close with what’s changing in drug mixes and where behavioural addictions may be heading next.

Subscribe to Addiction Medicine Made Easy, share this with a colleague, and leave a review so more people can find the show.

To contact Dr. Grover: ammadeeasy@fastmail.com

Create Harmony

This is a podcast about setting an intentional rhythm, savoring life’s blessings and...

Listen on: Apple Podcasts Spotify

Ibogaine is being talked about like a moonshot for addiction treatment and mental health. But when a substance is powerful enough to reshape cravings, mood, and perception, it is also powerful enough to hurt people when the science and safety systems lag behind.

This is Dr. Casey Grover and Addiction Medicine Made Easy, and this is a recording of a lecture that digs into what ibogaine is, why it’s back in US headlines, and how real people are already accessing ibogaine clinics just across the border. We walk through a cautionary story of a patient told she was “cured,” only to relapse immediately, and use that to underline a central point: no single intervention replaces a durable recovery plan.

You’ll hear a clear, clinician-friendly breakdown of ibogaine’s proposed mechanisms across multiple brain pathways (dopamine, serotonin, NMDA, opioid receptors, and more), what the ibogaine experience is typically like across its phases, and why this psychedelic therapy is not “benign.” We spend serious time on ibogaine safety, including QT prolongation, torsades de pointes, ventricular tachycardia, and how underlying heart conditions or mixing substances can turn treatment into tragedy.

Finally, we get geeky about evidence. We explain the different types of research studies, why “the plural of anecdote is not data,” and what the best available studies actually show for cravings, opioid withdrawal, PTSD, depression, and cocaine use. If you’re considering ibogaine for opioid addiction, ibogaine detox, or ibogaine for PTSD, we close with practical guidance on what we recommend today: medication assisted treatment like buprenorphine, methadone, or naltrexone, plus groups and individual therapy, with any experimental route followed by standard recovery work.

Subscribe, share this with someone who’s curious about ibogaine, and leave a review so more people can find careful, compassionate addiction medicine.

To contact Dr. Grover: ammadeeasy@fastmail.com

Create Harmony

This is a podcast about setting an intentional rhythm, savoring life’s blessings and...

Listen on: Apple Podcasts Spotify

You can look put-together, build a big career, and still be drowning the moment the door closes. That tension sits at the heart of our conversation with Louise Barnett, host of the Unmasking Sobriety and Mental Health Podcast and author of Tainted Love: A Bipolar Memoir. She walks us through what it feels like when bipolar I disorder first shows up, why it can take years to get the right diagnosis, and how shame quietly pushes people toward secrecy, self-harm, and substance use.

We talk honestly about addiction and bipolar disorder as a linked story, not two separate problems. Louise explains how alcohol and drugs played different roles across the mood spectrum: amplifying the invincible energy of mania, then numbing the crash of depression. She also shares what it meant to be “high functioning” in public while blacking out at night, and why appearance and performance can accidentally protect the illness from being seen.

The most practical part of this conversation is what stability looks like now. Louise breaks down the pillars that keep her regulated, including medication, therapy, lifestyle, sobriety, nervous system regulation, and emotional regulation, plus the boundaries that protect her energy as a parent and a creator. She leaves us with a simple, powerful invitation: find your people and start telling the truth, one safe step at a time.

Subscribe for more conversations at the intersection of mental health and addiction recovery, and if this resonates, share it with a friend and leave a rating or review.

To learn more about Louise's work: https://www.louisebarnett.com/

To contact Dr. Grover: ammadeeasy@fastmail.com

To learn more about the podcast: https://www.addictionmedicinemadeeasy.com/

Create Harmony

This is a podcast about setting an intentional rhythm, savoring life’s blessings and...

Listen on: Apple Podcasts Spotify

PTSD isn’t always born in a firefight or a resuscitation bay. Sometimes it grows quietly while you sit at a computer, doing your job well, watching the worst parts of humanity play out on screen. We sit down with Dr John Tullius, a former CIA officer and current professor at the Naval Postgraduate School, to talk about post-traumatic stress disorder, vicarious trauma, and the unique toll of open source intelligence in the social media era.

John shares what changed in his work with the CIA after 9/11, how analysts shifted from newspapers and radio to high-volume internet monitoring, and why repeated exposure to torture and killing can be one of the most pernicious pathways to PTSD. We dig into the cultural and organisational barriers that keep people silent, then unpack a surprisingly effective intervention: a psychologist who designed group sessions for safety and anonymity and ultimately got most staff to seek help. If you lead teams in intelligence, law enforcement, military units, or first responder organisations, you’ll take away concrete ideas you can apply.

We also connect it to healthcare worker PTSD and burnout, including what it feels like when a difficult patient story or a child’s death triggers a body-level stress response. We talk screening, prevention, and why “I’m fine” can hide a lot, plus the uncomfortable truth that alcohol often becomes the go-to numbing strategy in high stress professions. Subscribe for more conversations like this, share this with someone who needs it, and leave a review so more people can find the show.

To contact Dr. Grover: ammadeeasy@fastmail.com

To learn more about the podcast: https://www.addictionmedicinemadeeasy.com/

Create Harmony

This is a podcast about setting an intentional rhythm, savoring life’s blessings and...

Listen on: Apple Podcasts Spotify

Stigma doesn’t just hurt feelings, it changes medical decisions, family dynamics, and whether someone stays in care long enough to recover. That’s why we sat down with Jeanne Foot, founder and CEO of the Recovery Concierge and host of the Naturally High Podcast, for an honest conversation about what stigma against substance use disorders looks like in real life and what we can do differently.

We trace stigma from the personal to the systemic: Jeanne’s experience entering recovery in the early 1990s, the shame that follows families when a child is struggling, and the quiet “whispering” that keeps people isolated. We also talk about stigma in healthcare, including how people in alcohol withdrawal or opioid withdrawal can be treated as if they don’t deserve comfort or evidence-based care, even though alcohol detox can be fatal and fentanyl has made relapse risk terrifyingly high.

From there, we get practical. We share how compassion and advocacy help clients face judgment without bolting from care, why nervous system regulation tools matter in the hardest moments, and how fundamentals like sleep, nutrition, and movement can support mental health and addiction recovery alongside therapy and medication. We also dig into language, why labels can wound, and why the best recovery plan is the one that fits the person, whether that’s AA, SMART Recovery, peer support, or something unconventional that actually works.

If you care about addiction medicine, harm reduction, trauma-informed care, or supporting a loved one, hit play, then subscribe, share with someone who needs it, and leave a review so more people can find the show.

To learn about The Recovery Concierge: https://therecoveryconcierge.com/

To check out the Naturally High podcast: https://naturallyhigh.transistor.fm/

To contact Dr. Grover: ammadeeasy@fastmail.com

Create Harmony

This is a podcast about setting an intentional rhythm, savoring life’s blessings and...

Listen on: Apple Podcasts Spotify

Trauma-informed care is often explained with jargon, but we think it lands best as a promise: we will help you feel safe. Dr Casey Grover sits down with psychologist Dr Angela Chanter, Chief Clinical Officer at Sierra Health and Wellness, to translate that promise into what it looks like in real addiction treatment settings, especially detox and residential rehab where every sound, shift change, and schedule surprise can hit like a trigger.

We talk about how consistency becomes a clinical intervention, why leadership and communication are essential when a program has to pivot, and what “service-minded” care looks like without slipping into control or shame. Dr. Grover also shares his own experience with PTSD from emergency medicine and why the emergency department can unintentionally become trauma-worsening care for both patients and clinicians. From there, we connect the dots between clinician wellness, compassion fatigue, and the ability to stay present when people are struggling.

On the clinical side, we dig into restoring agency as a cornerstone of trauma recovery and substance use disorder treatment. We cover practical approaches like written exposure therapy and therapeutic journaling, skills from DBT and CBT, and how good aftercare planning supports long-term recovery through step-down options like PHP and IOP. We also discuss individualising care for survivors of domestic violence and sexual assault, including when gender-specific groups or programs can help someone feel safe enough to do the work.

If this conversation helps you see addiction medicine and trauma-informed care in a new way, subscribe, share it with a colleague or friend, and leave a rating or review so more people can find the show.

To learn more about Dr. Chanter's work:

To contact Dr. Grover: ammadeeasy@fastmail.com

Create Harmony

This is a podcast about setting an intentional rhythm, savoring life’s blessings and...

Listen on: Apple Podcasts Spotify

A prescription is supposed to help you get your life back. What happens when it quietly takes it away instead? I sit down with Stephanie Starr, a program manager and graduate student, whose search for mental health support after a traumatic birth turned into a devastating chain of misdiagnosis, escalating medications, and loss of trust in healthcare.

Stephanie walks us through being told she had bipolar disorder, being put on a rotating “cocktail” of psychiatric meds, and how side effects and instability can snowball into riskier choices, deeper shame, and substance use. We talk openly about benzodiazepines, the warning signs of a pill mill style clinic, and why “just follow doctor’s orders” is not enough when the diagnosis is shaky and the treatment plan only involves more and more medication. Her story also includes the realities of trauma, a suicide attempt, and the way stigma can show up in the very places people go for help.

From there, we shift into recovery and what actually sustains it. Stephanie shares how faith and a higher power became central for her, while also naming the harm that can happen in faith-based recovery spaces that push “just pray it away” thinking or shame people who need medication. We dig into emotional sobriety, AA-style accountability, therapy tools like EMDR, and how learning to tolerate discomfort can be a turning point in addiction recovery.

If this conversation helps you, subscribe, share it with someone who needs hope, and leave a review so more people can find the show.

To contact Dr. Grover: ammadeeasy@fastmail.com

Create Harmony

This is a podcast about setting an intentional rhythm, savoring life’s blessings and...

Listen on: Apple Podcasts Spotify

Psychiatric meds can feel like a maze when someone is trying to get sober and also sleep, focus, and stop panic spirals all in the same week. We made this updated, practical overview to simplify psychopharmacology for addiction treatment and recovery, using plain language and real clinical decision-making instead of jargon or hype.

We start by clearing up a viral rumor and then zoom out to how medications are actually created: research pathways, FDA indications, “me-too” drugs, and why off-label prescribing is so common in psychiatry. From there, we walk through the major medication classes and what they are truly used for, including antidepressants (SSRIs, SNRIs, mirtazapine, bupropion), anxiety and insomnia options that are less risky in recovery, and the basics of antipsychotics and mood stabilisers for severe symptoms like psychosis and bipolar disorder. We also touch on pharmacogenomics testing such as GeneSight and why individual response can still require careful trial and adjustment.

Because addiction medicine demands extra caution, we spend real time on benzodiazepine risks, why Z-drugs like Ambien can be problematic, and what we reach for instead when someone needs immediate anxiety relief while antidepressants take weeks to work. We wrap with a clinical case that shows how we prioritise conditions, pick meds that can treat more than one target, and avoid starting too many at once.

If this helps you, subscribe, share it with a colleague, and leave a rating or review so more people can find the show.

To contact Dr. Grover: ammadeeasy@fastmail.com

Create Harmony

This is a podcast about setting an intentional rhythm, savoring life’s blessings and...

Listen on: Apple Podcasts Spotify